Your browser doesn't support javascript.
loading
Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis-Associated Interstitial Lung Disease.
Papazoglou, Anna; Huang, Mengqi; Bulik, Melissa; Lafyatis, Annika; Tabib, Tracy; Morse, Christina; Sembrat, John; Rojas, Mauricio; Valenzi, Eleanor; Lafyatis, Robert.
Afiliación
  • Papazoglou A; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Huang M; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Bulik M; Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Lafyatis A; Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Tabib T; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Morse C; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Sembrat J; Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Rojas M; Division of Pulmonary, Critical Care and Sleep Medicine, Ohio State University, Columbus.
  • Valenzi E; Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Lafyatis R; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Arthritis Rheumatol ; 74(12): 2003-2014, 2022 12.
Article en En | MEDLINE | ID: mdl-35849803
ABSTRACT

OBJECTIVE:

Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is the leading cause of death in patients with SSc with unclear pathogenesis and limited treatment options. Evidence strongly supports an important role for profibrotic secreted phosphoprotein 1 (SPP1)-expressing macrophages in SSc-ILD. This study was undertaken to define the transcriptome and chromatin structural changes of SPP1 SSc-ILD macrophages in order to better understand their role in promoting fibrosis and to identify transcription factors associated with open chromatin driving their altered phenotype.

METHODS:

We performed single-cell RNA sequencing (scRNA-Seq) on 11 explanted SSc-ILD and healthy control lung samples, as well as single-cell assay for transposase-accessible chromatin sequencing on 5 lung samples to define altered chromatin accessibility of SPP1 macrophages. We predicted transcription factors regulating SPP1 macrophages using single-cell regulatory network inference and clustering (SCENIC) and determined transcription factor binding sites associated with global alterations in SPP1 chromatin accessibility using Signac/Seurat.

RESULTS:

We identified distinct macrophage subpopulations using scRNA-Seq analysis in healthy and SSc-ILD lungs and assessed gene expression changes during the change of healthy control macrophages into SPP1 macrophages. Analysis of open chromatin validated SCENIC predictions, indicating that microphthalmia-associated transcription factor, transcription factor EB, activating transcription factor 6, sterol regulatory element binding transcription factor 1, basic helix-loop-helix family member E40, Kruppel-like factor 6, ETS variant transcription factor 5, and/or members of the activator protein 1 family of transcription factors regulate SPP1 macrophage differentiation.

CONCLUSION:

Our findings shed light on the underlying changes in chromatin structure and transcription factor regulation of profibrotic SPP1 macrophages in SSc-ILD. Similar alterations in SPP1 macrophages may underpin fibrosis in other organs involved in SSc and point to novel targets for the treatment of SSc-ILD, specifically targeting profibrotic macrophages.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Pulmonares Intersticiales Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Arthritis Rheumatol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Pulmonares Intersticiales Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Arthritis Rheumatol Año: 2022 Tipo del documento: Article